logo
  • Home
  • News
Menu

Syros Pharmaceuticals Is A Buy As New Trials Start

Home / Stock Analysis / Syros Pharmaceuticals Is A Buy As New Trials Start
Article feature image

Syros Pharmaceuticals Is A Buy As New Trials Start

20 Nov Stock Analysis

wildpixel/iStock via Getty Images
In the high risk/high reward world of small, clinical stage pharmaceutical companies, one of my favorites is Syros Pharmaceuticals (SYRS). Syros is focused on controlling gene expression as a potential cure for cancers….

Click here to view the original article.

Tags:
Global, Seeking Alpha
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

17200754405824098873023.jpg
+

Google’s stock price has risen more than NVIDIA’s within the year, returning it to the list of popular AI investment stocks.

17 Sep Stock Analysis
8e268fffb3551beb1c0b297318cf4b89.jpeg
+

Oracle Sparks Bubble Talk With Stock Price in Dot-Com Territory

17 Sep Stock Analysis

recent post

  • image2-1021.jpg

    Shib Inu Price Predictions Vs Record-Breaking

    Sep 17 2025
  • 68cb397ed857580e5216284d_68cb397d550d0babdba8ad8e_lastImage.png

    What Can Crypto-Friendly SMEs Learn from

    Sep 17 2025
  • 68cb33dd4f514785a6184e0f_68cb33dca03f5afcfc9ad502_lastImage.png

    Crypto Investments: Navigating Kiyosaki’s Critique and

    Sep 17 2025
  • kate-cooper_OKX_smsfa_fr1psf.jpg

    New SMSF crypto expansion caters for

    Sep 17 2025
  • Flipping-Bitcoin-small-1.jpg

    Crypto.com Selected By ZOOZ Power To

    Sep 17 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.